Brickell Biotech Inc (NASDAQ:BBI)
| 0.83 BATS BZX Real-Time Price As of 1:10pm ET |  +0.0485 / +6.21%Today’s Change | 0.71 Today|||52-Week Range 4.29 | -44.67% Year-to-Date |
Latest BBI News | Press Releases
| AnGes, Brickell Biotech collaborate for COVID-19 DNA vaccine candidate Sep 08 / Seeking Alpha - Paid Partner Content | Brickell Biotech rallies; initiated BUY at Lake Street Capital Aug 28 / Seeking Alpha - Paid Partner Content |
| Brickell Biotech nabs Japanese patent covering ingredient in topical gel for excessive sweating Aug 31 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 0.78 |
| Today’s open | 0.85 |
| Day’s range | 0.81 - 0.87 |
| Volume | 214,440 |
| Average volume (3 months) | 2,199,633 |
| Market cap | $23.9M |
Data as of 1:10pm ET, 09/25/2020
Growth & Valuation
| Earnings growth (last year) | +13.62% |
| Earnings growth (this year) | +76.44% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +388.10% |
| P/E ratio | NM |
| Price/Sales | 0.57 |
| Price/Book | 0.96 |
Competitors
Data as of 1:27pm ET, 09/25/2020
Financials
| Next reporting date | November 11, 2020 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $7.9M |
| Annual profit (last year) | -$23.9M |
| Net profit margin | -301.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
